12 drugs in shortage
(By: Ella Jeffries for Becker’s Hospital Review) The number of active drug shortages has declined sharply since June, according to
Read More
FDA
American Action Forum Weighs In on 2026 Health Policy Interest Areas
With drug pricing initiatives pacing the way, American Action Forum (AAF) offers a post today reviewing key changes to the
Read MoreProposed Medicare Advantage rule aims to broaden hemp coverage
(By: Elizabeth Casolo for Becker’s Hospital Review) CMS’s proposed Medicare Advantage rule for 2027 includes more leeway for hemp coverage.
Read MoreFDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
(By Arthur Allen for KFF Health News) While the FDA is streamlining regulation of copycat versions of the expensive drugs
Read MoreFDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
(Source – www.hhs.gov) WASHINGTON— OCTOBER 29, 2025 — The U.S. Food and Drug Administration (FDA) today announced significant action to
Read MoreAn Alzheimer’s pill appears to protect some in a high-risk population
(By Jon Hamilton for NPR published October 29, 2025) In April, the future was looking bleak for an experimental Alzheimer’s
Read More6 drugs in shortage
(By: Alexandra Murphy for Becker’s Hospital Review) Here are six new drug shortages and discontinuations, according to drug supply databases
Read MoreFDA moves to cut expert panel input on new drugs
(By: Alexandra Murphy for Becker’s Hospital Review) The FDA is moving to scale back its long-standing use of expert panels
Read MoreWegovy gains new approval: 3 GLP-1 updates
(By: Paige Twenter for Becker’s Hospital Review) Novo Nordisk’s popular weight loss drug, Wegovy, is the first and only GLP-1
Read MoreThese scientists found Alzheimer’s in their genes. Here’s what they did next
(By Jon Hamilton for NPR) People who inherit two copies of a gene variant called APOE4 have a 60% chance
Read More